We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
19 result(s) found, displaying 11 to 19
-
-
Australian public assessment report (AusPar)Brukinsa (zanubrutinib) for the treatment of adult patients with mantle cell lymphoma
-
Australian public assessment report (AusPar)Brukinsa (zanubrutinib) for the treatment of of adult patients with Waldenström’s macroglobulinaemia
-
-
-
-
-
-